Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma.

ABSTRACT:

SUBMITTER: Di Staso R 

PROVIDER: S-EPMC11544145 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature